Management of Symptomatic Hydronephrosis in Pregnancy

Initial Assessment and Conservative Management

Hydronephrosis is common during pregnancy, affecting 70-90% of pregnant women, typically appearing after 20 weeks due to mechanical compression from the enlarging uterus and hormonal changes that reduce ureteric peristalsis 2, 3
Only 0.2-4.7% of pregnant women develop symptomatic hydronephrosis requiring intervention, with higher prevalence in advancing trimesters 4
Initial management should include conservative measures: adequate rest, hydration, analgesia, and antiemetics, which have a 70-80% success rate in cases without infection 2

Prolonged hospitalization requirements are an indication for intervention, as in the case of a 26-week pregnant woman with persistent moderate flank pain and hydronephrosis 2
Risk of preterm labor if left untreated is a significant concern, and intervention may be necessary to prevent this outcome 2, 1

Retrograde ureteral stenting is the preferred first-line intervention for pregnant patients with persistent symptomatic hydronephrosis requiring treatment, according to the American College of Radiology 1, 5
Advantages of retrograde stenting include minimal radiation exposure to the fetus, significant advancements in ureteroscopy techniques, and improved imaging resolution and smaller caliber scopes 2

Fluoroscopy during stent placement should be avoided or minimized to reduce radiation exposure to the fetus 2
Ultrasound guidance can be used to confirm appropriate stent positioning, and the stent typically remains in place until after delivery 2
Complications to monitor for include ureteral injury, perforation, or sepsis that could lead to preterm labor 2

PCN should be considered when retrograde ureteral catheterization is not technically possible, and can safely provide temporary urinary tract decompression 2, 6
The incidence of spontaneous abortion or preterm labor related to PCN tube placement is exceedingly low, and PCN can be performed using ultrasound guidance alone to limit radiation exposure to the fetus 6

Percutaneous antegrade ureteral stenting is not recommended during pregnancy due to increased fluoroscopy time and radiation exposure to the fetus, as recommended by the American College of Radiology 6
Prolonged manipulation in cases with active infection can lead to systemic inflammatory response syndrome or urosepsis, and a multidisciplinary approach is essential for optimal management 6
For cases with urolithiasis, the risk of preterm labor completely ceases once the stone passes or is removed, according to the American College of Radiology 2

Close monitoring for signs of infection or worsening obstruction is necessary, and definitive treatment of any underlying cause is typically delayed until after delivery 2, 6